Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_012307.5(EPB41L3):āc.2575G>Cā(p.Glu859Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00139 in 1,614,070 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt.
EPB41L3 (HGNC:3380): (erythrocyte membrane protein band 4.1 like 3) Predicted to enable cytoskeletal protein-membrane anchor activity. Predicted to be a structural constituent of cytoskeleton. Predicted to be involved in several processes, including nervous system development; paranodal junction maintenance; and protein localization to paranode region of axon. Located in cell-cell junction and plasma membrane. Biomarker of meningioma. [provided by Alliance of Genome Resources, Apr 2022]
Computational evidence support a benign effect (MetaRNN=0.0057339966).
BP6
Variant 18-5397324-C-G is Benign according to our data. Variant chr18-5397324-C-G is described in ClinVar as [Benign]. Clinvar id is 777266.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0073 (1112/152330) while in subpopulation AFR AF= 0.0252 (1048/41570). AF 95% confidence interval is 0.0239. There are 15 homozygotes in gnomad4. There are 560 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.